Genome Medicine is an online peer-reviewed journal which publishes open access
research articles of outstanding quality in all areas of medicine studied from a
genomic or post-genomic perspective. The journal has a special focus on the latest
technologies and findings that impact on the understanding and management of
human health and disease.
In addition to publishing high-quality research, Genome Medicine serves the
international research community as a forum for the discussion and critical review of
information about all areas of medicine informed by genomic research.
Subjects include, but are not limited to:






Significant advances in the understanding of the genetics, genomics, and
epigenetics of disease
Computational and systems approaches, including proteomics, metabolomics
and transcriptomics, to the understanding and management of disease
Genomic epidemiology and public health genomics
The application of genomic and post-genomic technologies to clinical practice,
with special emphasis on diagnostics and therapeutics
Personalized medicine
Ethical, social and legal issues relating to genomic medicine and personalized
medicine
Content overview
Genome Medicine contains the following types of articles:





Research articles: reports of data from exceptional original research. These
articles will form the major content of the journal.
Reviews: include systematic and substantial coverage of mature subjects,
rapid coverage of fast-moving areas, evaluations of progress in specified
areas, and critical assessments of emerging technologies. Reviews will
generally be commissioned by the editorial staff, though suggestions of topics
are always welcome.
Commentaries: short, focused and opinionated articles on any subject within
the journal's scope. These articles usually relate to contemporary issues and
are often written by opinion leaders invited by the Editorial Board.
Correspondence: may discuss material published in Genome Medicine or
particular issues of general interest to the readership. They may also present
a community announcement within the field of genomic and post-genomic
medicine.
Meeting reports: short descriptions of a conference that an author has
attended, which should focus on the key developments presented and
discussed at the meeting. These articles are usually commissioned but reports
and suggestions may also be submitted for the editors' consideration.
Peer review policies
Suitability of research for publication in Genome Medicine is dependent primarily on
the scientific validity and coherence of the work, as well as broad interest, as
assessed by reviewers and Editors.
Although Genome Medicine will not make general interest level an absolute criterion
for publication, it aims to provide its readership with the highest quality research and
information in genomic and post-genomic medicine, and will therefore focus on
articles of general and outstanding interest.
All submitted research papers are subject to immediate rapid screening by the
editors, in consultation with the Editorial Board if appropriate, to ensure they fall
within the scope of the journal. Contributors who are in doubt about the suitability of
their paper are welcome to send a presubmission enquiry. The editors will provide an
initial response to all presubmission enquiries and submitted articles within five
working days.
Manuscripts will be reviewed by internationally recognized experts in the fields of
genomic and post-genomic medicine selected in part from our Editorial Board.
Genome Medicine operates an anonymous peer review process. Reviews will be rapid
and the suitability of a paper for publication will be assessed solely on criteria of
scientific excellence. The editors will make every effort to give authors a decision
following peer review within four weeks of an article's submission. Articles are
published electronically as promptly as possible after they are accepted, and within
one month of acceptance.